Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Change in Accured Expenses (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Change in Accured Expenses for 4 consecutive years, with $22.1 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 33.79% year-over-year to $22.1 million; the TTM value through Dec 2025 reached -$277000.0, down 100.66%, while the annual FY2025 figure was -$277000.0, 100.66% down from the prior year.
  • Change in Accured Expenses was $22.1 million for Q4 2025 at Day One Biopharmaceuticals, up from $4.1 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $62.3 million in Q2 2024, with the low at -$51.9 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged $3.3 million across 4 years, with a median of $1.8 million in 2023.
  • Biggest YoY gain for Change in Accured Expenses was 3442.52% in 2024; the steepest drop was 4699.56% in 2024.
  • Over 4 years, Change in Accured Expenses stood at -$7.1 million in 2022, then surged by 182.46% to $5.9 million in 2023, then surged by 468.93% to $33.4 million in 2024, then tumbled by 33.79% to $22.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $22.1 million in Q4 2025, $4.1 million in Q3 2025, and $490000.0 in Q2 2025.